
AGN
Healthcare · Drug Manufacturers - General · $63.66B market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Mar 31, 2020
EPS trend, 90 days to now · -0.3% over 90 days · 30-day revisions 2 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Jan 29, 2019 | Time not confirmed | 4.15 | -12.83 | -409.2% |
| Oct 30, 2018 | Time not confirmed | 4.04 | -0.11 | -102.8% |
| Jul 26, 2018 | Time not confirmed | 4.13 | -1.39 | -133.7% |
| Apr 30, 2018 | Time not confirmed | 3.36 | -0.99 | -129.6% |
| Feb 6, 2018 | Time not confirmed | 4.74 | 8.68 | +83.1% |
Allergan plc, a pharmaceutical company, develops, manufactures, and commercializes branded pharmaceutical, device, biologic, surgical, and regenerative medicine products worldwide. The company operates in three segments: US Specialized Therapeutics, US General Medicine, and International. It offers a portfolio of products in various therapeutic areas, including medical aesthetics and dermatology, eye care,…